Aldeyra Therapeutics Inc (STU:137)
€ 4.609 -0.037 (-0.79%) Market Cap: 276.29 Mil Enterprise Value: 184.32 Mil PE Ratio: 0 PB Ratio: 3.43 GF Score: 39/100

Q1 2022 Aldeyra Therapeutics Inc Earnings Call Transcript

May 05, 2022 / 12:00PM GMT
Release Date Price: €2.65 (-1.38%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics First Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session.

I would now like to hand over the conference to company's Chief Financial Officer, Mr. Joshua Reed. Please go ahead, sir.

Joshua Reed
Aldeyra Therapeutics, Inc. - CFO

Good morning, everyone. With me today are Dr. Todd Brady, President and Chief Executive Officer; and Bruce Greenberg, incoming Interim CFO. This morning, we issued a press release reporting our financial results for the quarter ended March 31, 2022. A copy of the press release is available on the Investors & Media section of our website, www.aldeyra.com.

Please note that this morning's conference call contains forward-looking statements regarding future events and the future performance of Aldeyra. Forward-looking statements include,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot